Prostate specific antigen levels following transurethral resection of the prostate

International Braz J Urol

Volumn 34, Issue 1, 2008, Pages 41-48

  Fonseca, Roberto C ^a   Gomes, Cristiano M ^a   Meireles, Elton B ^a   Freire, Geraldo C ^a   Srougi, Miguel ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Benign prostatic hyperplasia; Prostate specific antigen; Transurethral resection of prostate

Indexed keywords

EID: 41549096376     PISSN: 16775538     EISSN: 16776119     Source Type: Journal    
DOI: 10.1590/S1677-55382008000100007     Document Type: Article

References (17)

1. Aus G, Bergdahl S, Frosing R, Lodding P, Pileblad E, Hugosson J: Reference range of prostate-specific antigen after transurethral resection of the prostate. Urology. 1996;47:529-31.
2. Recker F, Kwiatkowski MK, Pettersson K, Piironen T, Lummen G, Huber A, et al.: Enhanced expression of prostate-specific antigen in the transition zone of the prostate. A characterization following prostatectomy for benign hyperplasia. Eur Urol. 1998; 33: 549-55.
3. Vesey SG, Goble NM, Stower MJ, Hammonds JC, Smith PJ: The effects of transurethral prostatectomy on serum prostate specific antigen. Br J Urol. 1988; 62: 347-51.
4. Scattoni V, Raber M, Montorsi F, Da Pozzo L, Brausi M, Calori G, et al.: Percent of free serum prostate-specific antigen and histological findings in patients undergoing open prostatectomy for benign prostatic hyperplasia. Eur Urol. 1999; 36: 621-30.
5. Marks LS, Dorey FJ, Rhodes T, Shery ED, Rittenhouse H, Partin AW, et al.: Serum prostate specific antigen levels after transurethral resection of prostate: a longitudinal characterization in men with benign prostatic hyperplasia. J Urol. 1996; 156: 1035-9.
6. Khiel R, Lemos AD, Stavalle JN, Ortiz V: Correlation between chronic prostatitis and prostate-specific antigen values. Int Braz J Urol. 2001; 27: 42-5.
7. AUA Practice Guidelines Committee: AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol. 2003; 170: 530-47.
8. Oesterling JE, Tekchandani AH, Martin SK, Bergstralh EJ, Reichstein E, Diamandis EP, et al.: The periurethral glands do not significantly influence the serum prostate specific antigen concentration. J Urol. 1996; 155: 1658-60.
9. Wolff JM, Boekels O, Borchers H, Jakse G, Rohde D: Altered prostate specific antigen reference range after transurethral resection of the prostate. Anticancer Res. 2000; 20: 4977-80.
10. De Nunzio C, Franco G, Iori F, Leonardo C, Minardi V, Laurenti C: Clinical and pressure-flow changes after long-term treatment with alfuzosin SR. Urol Int. 2003; 71: 31-6.
11. Rodrigues P, Lucon AM, Freire GC, Arap S: Urodynamic pressure flow studies can predict the clinical outcome after transurethral prostatic resection. J Urol. 2001; 165: 499-502.
12. Hammerer PG, McNeal JE, Stamey TA: Correlation between serum prostate specific antigen levels and the volume of the individual glandular zones of the human prostate. J Urol. 1995; 153: 111-4.
13. Nickel JC, Downey J, Young I, Boag S: Asymptomatic inflammation and/or infection in benign prostatic hyperplasia. BJU Int. 1999; 84: 976-81.
14. Kwak C, Ku JH, Kim T, Park DW, Choi KY, Lee E, et al.: Effect of subclinical prostatic inflammation on serum PSA levels in men with clinically undetectable prostate cancer. Urology. 2003; 62: 854-9.
15. Nadler RB, Humphrey PA, Smith DS, Catalona WJ, Ratliff TL: Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol. 1995; 154: 407-13.
16. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med. 1987;317:909-16.
17. Lloyd SN, Collins GN, McKelvie GB, Hehir M, Rogers AC: Predicted and actual change in serum PSA following prostatectomy for BPH. Urology. 1994; 43: 472-9.